Sandbox Reserved 1722: Difference between revisions
From Proteopedia
Jump to navigationJump to search
Paola Ariza (talk | contribs) No edit summary |
No edit summary |
||
| Line 36: | Line 36: | ||
==== ''DRY Motif'' ==== | ==== ''DRY Motif'' ==== | ||
The DRY motif is a proton microswitch that is located near the G-protein binding site C-terminal on TM3 <ref name="Schonegge"/>. It acts as an ion lock when the GPCR is not being activated, preventing unnecessary activation of the G-proteins <ref name="Zhou"/>. This motif is conserved in typical Class A GPCRS however, in MRGPRX2 it is only partially conserved. The arginine is conserved, while the aspartate is replaced by a glutamate and the tyrosine is replaced by a cysteine | The DRY motif is a proton microswitch that is located near the G-protein binding site C-terminal on TM3 <ref name="Schonegge"/>. It acts as an ion lock when the GPCR is not being activated, preventing unnecessary activation of the G-proteins <ref name="Zhou"/>. This motif is conserved in typical Class A GPCRS however, in MRGPRX2 it is only partially conserved. The arginine is conserved, while the aspartate is replaced by a glutamate and the tyrosine is replaced by a cysteine <ref name="Yang"/> <ref name="Sandoval">Sandoval, A., et al. "The Molecular Switching Mechanism at the Conserved D(E)RY Motif in Class-A GPCRs." Biophysical journal, 111(1), 79-89. https://doi.org/10.1016/j.bpj.2016.06.004 </ref>. The replacement of tyrosine for cysteine results in the helices coming closer together, creating a shallower binding pocket.<ref name="Zhou"/> | ||
==== ''Sodium Binding'' ==== | ==== ''Sodium Binding'' ==== | ||
| Line 51: | Line 51: | ||
==== Agonists ==== | ==== Agonists ==== | ||
[[Image:Agoniststogether.PNG |400px|right|thumb|'''Figure 3''': Structure of MRGPRX2 Agonists. (A) Structure of R-Zinc 3573. A cationic ligand selected for binding to MRGPRX2.<ref name="Yang">Yang, Fan, et al. "Structure, function and pharmacology of human itch receptor complexes." Nature, Nature Publishing Group, 17 November 2021, https://www.nature.com/articles/s41586-021-04077-y</ref> (B) Structure of Cortistatin-14 with resolved amino acids highlighted in green. These ligands were used as a probes for MRGPRX2 function and stabilization for structure determination.<ref name="Yang">Yang, Fan, et al. "Structure, function and pharmacology of human itch receptor complexes." Nature, Nature Publishing Group, 17 November 2021, https://www.nature.com/articles/s41586-021-04077-y</ref>]] | [[Image:Agoniststogether.PNG |400px|right|thumb|'''Figure 3''': Structure of MRGPRX2 Agonists. (A) Structure of R-Zinc 3573. A cationic ligand selected for binding to MRGPRX2.<ref name="Yang">Yang, Fan, et al. "Structure, function and pharmacology of human itch receptor complexes." Nature, Nature Publishing Group, 17 November 2021, https://www.nature.com/articles/s41586-021-04077-y</ref> (B) Structure of Cortistatin-14 with resolved amino acids highlighted in green. These ligands were used as a probes for MRGPRX2 function and stabilization for structure determination.<ref name="Yang">Yang, Fan, et al. "Structure, function and pharmacology of human itch receptor complexes." Nature, Nature Publishing Group, 17 November 2021, https://www.nature.com/articles/s41586-021-04077-y</ref>]] | ||
| Line 65: | Line 64: | ||
=== 2. MRGPRX2 interaction with G-Protein === | === 2. MRGPRX2 interaction with G-Protein === | ||
[[Image:Gq_and_Gi_snip.PNG|300px|right|thumb|'''Figure 4''': | [[Image:Gq_and_Gi_snip.PNG|300px|right|thumb|'''Figure 4''': Comparison of the conformational change for MRGPRX2 (light blue) coupled with Gq (teal) and MRGPRX2 (pink) coupled with Gi (purple).<ref name="Cao"/> PDB entry [https://www.rcsb.org/structure/7S8N 7S8N] and [https://www.rcsb.org/structure/7S8O 7S8O]]] | ||
Once the ligand is bound, MRGPRX2 undergoes a conformational change that is transmitted through to the [https://en.wikipedia.org/wiki/G_protein#:~:text=G%20proteins%2C%20also%20known%20as,a%20cell%20to%20its%20interior. G-protein]. This conformational change is affected by the aforementioned deviances from Class A GPCRs. Rather than a large conformational change, a subtle one is induced. This will allow MRGPRX2 to interact with a G-protein. <scene name='90/904327/Gproteins/2'>G-proteins</scene> are composed of 3 subunits; α, β, and γ. When activated, the receptor acts as a Guanine nucleotide factor (GEF) which will allow the Gα subunit to have its GDP be replaced by a GTP. This will cause the Gα subunit to dissociate from the dimer Gβγ. The Gα subunit is then able to act as a secondary messenger to begin the signal transduction in the cell. MRGPRX2 interacts with two different types of G-proteins; Gi and Gq. These G-proteins are activated by similar interactions with the receptor however, they are structurally different and changes in the induced conformation are observed (Figure 4 | Once the ligand is bound, MRGPRX2 undergoes a conformational change that is transmitted through to the [https://en.wikipedia.org/wiki/G_protein#:~:text=G%20proteins%2C%20also%20known%20as,a%20cell%20to%20its%20interior. G-protein]. This conformational change is affected by the aforementioned deviances from Class A GPCRs. Rather than a large conformational change, a subtle one is induced. This will allow MRGPRX2 to interact with a G-protein. <scene name='90/904327/Gproteins/2'>G-proteins</scene> are composed of 3 subunits; α, β, and γ. When activated, the receptor acts as a Guanine nucleotide factor (GEF) which will allow the Gα subunit to have its GDP be replaced by a GTP. This will cause the Gα subunit to dissociate from the dimer Gβγ. The Gα subunit is then able to act as a secondary messenger to begin the signal transduction in the cell. MRGPRX2 interacts with two different types of G-proteins; Gi and Gq. These G-proteins are activated by similar interactions with the receptor however, they are structurally different and changes in the induced conformation are observed (Figure 4). | ||
=== 3.After G-Protein Activation === | === 3.After G-Protein Activation === | ||